- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.45 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PGH: PHOSPHOGLYCOLOHYDROXAMIC ACID(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
ZN.2: 4 residues within 4Å:- Chain A: H.83, H.180, H.208
- Ligands: PGH.1
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:H.83, A:H.180, A:H.208
ZN.11: 4 residues within 4Å:- Chain B: H.83, H.180, H.208
- Ligands: PGH.10
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:H.83, B:H.180, B:H.208
ZN.22: 4 residues within 4Å:- Chain C: H.83, H.180, H.208
- Ligands: PGH.21
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:H.83, C:H.180, C:H.208
ZN.31: 4 residues within 4Å:- Chain D: H.83, H.180, H.208
- Ligands: PGH.30
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:H.83, D:H.180, D:H.208
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.3: 7 residues within 4Å:- Chain A: A.179, H.180, G.181, Y.183, G.209, S.211
- Ligands: PGH.1
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.181
NA.12: 7 residues within 4Å:- Chain B: A.179, H.180, G.181, Y.183, G.209, S.211
- Ligands: PGH.10
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:A.179, B:Y.183
NA.23: 7 residues within 4Å:- Chain C: A.179, H.180, G.181, Y.183, G.209, S.211
- Ligands: PGH.21
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Y.183
NA.32: 7 residues within 4Å:- Chain D: A.179, H.180, G.181, Y.183, G.209, S.211
- Ligands: PGH.30
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Y.183, D:S.211
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 7 residues within 4Å:- Chain A: S.2, S.70, T.71, M.75
- Chain B: H.95
- Ligands: EDO.16, EDO.17
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: L.9, P.44, V.45, M.75, P.76, L.77, A.78
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: D.190, Q.192, R.193, E.196
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: Q.32, E.36, Y.73, R.261
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: Y.63, H.95, A.96, G.97
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: L.9, D.12, Y.18, P.44, R.283, I.284
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain B: P.44, V.45, P.76, L.77, A.78
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain B: S.2, S.70, T.71, N.74, M.75, P.76
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain B: Y.63, H.95, A.96, G.97
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain A: N.74, P.76
- Chain B: H.95, F.123, Q.127
- Ligands: EDO.4, EDO.17
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: N.74
- Chain B: H.95
- Ligands: EDO.4, EDO.16
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain B: S.106, F.108, P.109, R.137, A.152
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain B: V.114, K.115, K.118
Ligand excluded by PLIPEDO.20: 2 residues within 4Å:- Chain B: D.122, F.123
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain C: S.2, S.70, T.71, M.75
- Chain D: H.95
- Ligands: EDO.36, EDO.37
Ligand excluded by PLIPEDO.25: 7 residues within 4Å:- Chain C: L.9, P.44, V.45, M.75, P.76, L.77, A.78
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain C: D.190, Q.192, R.193, E.196
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain C: Q.32, E.36, Y.73, R.261
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain C: Y.63, H.95, A.96, G.97
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain C: L.9, D.12, Y.18, P.44, R.283, I.284
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain D: P.44, V.45, P.76, L.77, A.78
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain D: S.2, S.70, T.71, N.74, M.75, P.76
Ligand excluded by PLIPEDO.35: 4 residues within 4Å:- Chain D: Y.63, H.95, A.96, G.97
Ligand excluded by PLIPEDO.36: 7 residues within 4Å:- Chain C: N.74, P.76
- Chain D: H.95, F.123, Q.127
- Ligands: EDO.24, EDO.37
Ligand excluded by PLIPEDO.37: 4 residues within 4Å:- Chain C: N.74
- Chain D: H.95
- Ligands: EDO.24, EDO.36
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain D: S.106, F.108, P.109, R.137, A.152
Ligand excluded by PLIPEDO.39: 3 residues within 4Å:- Chain D: V.114, K.115, K.118
Ligand excluded by PLIPEDO.40: 2 residues within 4Å:- Chain D: D.122, F.123
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hall, D.R. et al., Structure of Tagatose-1,6-Bisphosphate Aldolase; Insight Into Chiral Discrimination, Mechanism and Specificity of Class II Aldolases. J.Biol.Chem. (2002)
- Release Date
- 2002-06-18
- Peptides
- TAGATOSE-BISPHOSPHATE ALDOLASE AGAY: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.45 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PGH: PHOSPHOGLYCOLOHYDROXAMIC ACID(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hall, D.R. et al., Structure of Tagatose-1,6-Bisphosphate Aldolase; Insight Into Chiral Discrimination, Mechanism and Specificity of Class II Aldolases. J.Biol.Chem. (2002)
- Release Date
- 2002-06-18
- Peptides
- TAGATOSE-BISPHOSPHATE ALDOLASE AGAY: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B